The Effects of Warm Showers Application in Birth on Birth Pain, Birth Satisfaction and Birth Results
Midwife Öznur Hayat Öktem
2 other identifiers
interventional
78
1 country
1
Brief Summary
The use of non-pharmacological methods in labor pain is very important in order to improve the birth process, increase comfort and provide relaxation. The role of midwives, acting as patient advocate is to maintain comfort throughout the birth process. In order to do this, she should know very well the non-pharmacological methods to be applied to the pregnant woman and choose the most appropriate one. Applying a warm shower, which is one of the non-pharmacological methods; the uterus Increases perfusion, makes labor painless felt, increases the release of oxytocin, and decreases the release of stress hormones. In addition, while reducing the intervention rates, it improves birth and newborn outcomes and affects positively. Purpose of the research; labor pain of warm shower application, labor to evaluate the effect on satisfaction and birth outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2022
CompletedFirst Submitted
Initial submission to the registry
April 2, 2022
CompletedFirst Posted
Study publicly available on registry
April 19, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 15, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 15, 2023
CompletedJanuary 21, 2026
January 1, 2026
1 year
April 2, 2022
January 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Labor Pain
Visual analog scale:On a 10 cm (100 mm.) ruler, which is marked painlessness on one end and the most severe pain possible on the other, the patient expresses his or her own pain by drawing a line, pointing or pointing. The length of the distance from the point where there is no pain to the point marked by the patient is measured in centimeters and the numerical value found shows the severity of the patient's pain.
Baseline (Before the cervical dilation)
Labor pain
Visual analog scale.On a 10 cm (100 mm.) ruler, which is marked painlessness on one end and the most severe pain possible on the other, the patient expresses his or her own pain by drawing a line, pointing or pointing. The length of the distance from the point where there is no pain to the point marked by the patient is measured in centimeters and the numerical value found shows the severity of the patient's pain.
10 minutes after the cervical dilation
Labor pain
Visual analog scale.On a 10 cm (100 mm.) ruler, which is marked painlessness on one end and the most severe pain possible on the other, the patient expresses his or her own pain by drawing a line, pointing or pointing. The length of the distance from the point where there is no pain to the point marked by the patient is measured in centimeters and the numerical value found shows the severity of the patient's pain.
20 minutes after the cervical dilation
Secondary Outcomes (1)
Birth satisfaction
Pregnant women in both groups will be visited by the researcher in the postpartum service within the first 24 hours postpartum and BSC will be applied.
Study Arms (2)
Warm Showers Application
EXPERIMENTALIn the experimental group, a 20-minute warm shower (37 °C) will be administered when cervical dilation reaches at least 4 cm and again at 7 cm. The control group will receive standard care only. The hot shower will be applied to the sacral area, lower abdomen, and groin regions.
Standard Intrapartum Care
NO INTERVENTIONNo intervention will be provided to the control group. At the stages when cervical dilation reaches 4 cm and 7 cm, pain will be evaluated using the VAS at baseline, 10 and 20 minutes.
Interventions
In the experimental group, a 20-minute warm showers (37 °C) will be administered when cervical dilation reaches at least 4 cm and again at 7 cm. The control group will receive standard care only. The warm showers will be applied to the sacral area, lower abdomen, and groin regions. Throughout the intervention, the researcher will accompany the pregnant women to ensure safety and proper implementation of the procedure. Pain will be assessed using the VAS scale before the intervention and at 10 and 20 minutes after the intervention. The Birth Satisfaction Scale will be administered prior to discharge
Eligibility Criteria
You may qualify if:
- Between the ages of 18 and 35,
- Having a singleton fetus between 37-42 weeks of gestation,
- Planning a a spontaneous vaginal birth,
- Having a cervical dilatation \<5 cm.
- Having a fetus weighing between 2500-4000 grams,
You may not qualify if:
- Being short (\<145cm),
- Being obese (BMI \>30),
- Receiving pharmacological or non-pharmacological intervention for labor pain,
- Having chronic diseases during pregnancy (gestational diabetes, hypertension, preeclampsia,
- Undergoing operative vaginal delivery (forceps, vacuum),
- Making an emergency cesarean decision,
- Experiencing abnormal changes in fetal heart rates.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Öznur Hayat Öktem
Karabük, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Midwife, principal investigator
Study Record Dates
First Submitted
April 2, 2022
First Posted
April 19, 2022
Study Start
January 1, 2022
Primary Completion
January 15, 2023
Study Completion
January 15, 2023
Last Updated
January 21, 2026
Record last verified: 2026-01